These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8938914)

  • 21. Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
    Liemburg E; Sibeijn-Kuiper A; Bais L; Pijnenborg G; Knegtering H; van der Velde J; Opmeer E; de Vos A; Dlabac-De Lange J; Wunderink L; Aleman A
    Sci Rep; 2016 Feb; 6():21873. PubMed ID: 26903078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
    Reid MA; Salibi N; White DM; Gawne TJ; Denney TS; Lahti AC
    Schizophr Bull; 2019 Jan; 45(1):180-189. PubMed ID: 29385594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
    Bustillo JR; Chen H; Gasparovic C; Mullins P; Caprihan A; Qualls C; Apfeldorf W; Lauriello J; Posse S
    Biol Psychiatry; 2011 Jan; 69(1):19-27. PubMed ID: 20970118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy.
    Choe BY; Suh TS; Shinn KS; Lee CW; Lee C; Paik IH
    Invest Radiol; 1996 Jun; 31(6):345-52. PubMed ID: 8761867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study.
    Olbrich HM; Valerius G; Rüsch N; Buchert M; Thiel T; Hennig J; Ebert D; Van Elst LT
    World J Biol Psychiatry; 2008; 9(1):59-63. PubMed ID: 17853298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.
    Bertolino A; Callicott JH; Mattay VS; Weidenhammer KM; Rakow R; Egan MF; Weinberger DR
    Biol Psychiatry; 2001 Jan; 49(1):39-46. PubMed ID: 11163778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.
    Goldstein ME; Anderson VM; Pillai A; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex.
    Michael N; Erfurth A; Ohrmann P; Gössling M; Arolt V; Heindel W; Pfleiderer B
    Psychopharmacology (Berl); 2003 Jul; 168(3):344-6. PubMed ID: 12684737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia.
    Callicott JH; Bertolino A; Egan MF; Mattay VS; Langheim FJ; Weinberger DR
    Am J Psychiatry; 2000 Oct; 157(10):1646-51. PubMed ID: 11007719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.
    Molina V; Sánchez J; Reig S; Sanz J; Benito C; Santamarta C; Pascau J; Sarramea F; Gispert JD; Misiego JM; Palomo T; Desco M
    Schizophr Res; 2005 Mar; 73(2-3):209-19. PubMed ID: 15653263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
    Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
    Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
    Park SE; Choi NG; Jeong GW
    Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia.
    Bertolino A; Esposito G; Callicott JH; Mattay VS; Van Horn JD; Frank JA; Berman KF; Weinberger DR
    Am J Psychiatry; 2000 Jan; 157(1):26-33. PubMed ID: 10618009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study".
    Théberge J; Jensen JE; Rowland LM
    Biol Psychiatry; 2007 May; 61(10):1218-9; author reply 1219-20. PubMed ID: 16950227
    [No Abstract]   [Full Text] [Related]  

  • 37. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
    Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurochemical and structural correlates of executive dysfunction in schizophrenia.
    Rüsch N; Tebartz van Elst L; Valerius G; Büchert M; Thiel T; Ebert D; Hennig J; Olbrich HM
    Schizophr Res; 2008 Feb; 99(1-3):155-63. PubMed ID: 17616347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Online Effects of Transcranial Direct Current Stimulation in Real Time on Human Prefrontal and Striatal Metabolites.
    Hone-Blanchet A; Edden RA; Fecteau S
    Biol Psychiatry; 2016 Sep; 80(6):432-438. PubMed ID: 26774968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.